ISSN: 0306-5251
Journal Home
Journal Guideline
British Journal of Clinical Pharmacology Q1 Unclaimed
British Journal of Clinical Pharmacology is a journal indexed in SJR in Pharmacology and Pharmacology (medical) with an H index of 167. It has a price of 3429 €. It has an SJR impact factor of 1,046 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,046.
British Journal of Clinical Pharmacology focuses its scope in these topics and keywords: drug, healthy, review, study, acid, systematic, prescribing, oral, comparison, design, ...
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy: Open Choice
Type of publications:
Publication frecuency: -
3429 €
Inmediate OANPD
Embargoed OA0 €
Non OAMetrics
1,046
SJR Impact factor167
H Index409
Total Docs (Last Year)1287
Total Docs (3 years)16426
Total Refs4049
Total Cites (3 years)1111
Citable Docs (3 years)3.04
Cites/Doc (2 years)40.16
Ref/DocOther journals with similar parameters
Pharmacological Reviews Q1
Drug Resistance Updates Q1
Annual Review of Pharmacology and Toxicology Q1
Molecular Therapy Q1
Journal for ImmunoTherapy of Cancer Q1
Compare this journals
Aims and Scope
Best articles by citations
Quinine intoxications reported to the Scottish Poisons Information Bureau 1997-2002: a continuing problem
View moreNonspecific binding of drugs to human liver microsomes
View moreThe regulation of medical devices and the role of the Medical Devices Agency
View moreIndicators for Drug and Therapeutics Committees
View morePopulation PK and PK/PD modelling of microencapsulated octreotide acetate in healthy subjects
View moreEffect of rifampicin on the pharmacokinetics and pharmacodynamics of glimepiride
View moreEntry-into-human study with the novel immunosuppressant SDZ RAD in stable renal transplant recipients
View moreInhibitory effects of antiarrhythmic drugs on phenacetin O-deethylation catalysed by human CYP1A2
View moreRisk of suicide in users of beta-adrenoceptor blockers, calcium channel blockers and angiotensin converting enzyme inhibitors
View moreDecreased dromotropic response to verapamil despite pronounced increased drug concentration in rheumatoid arthritis
View morePlasma protein binding displacement interactions-why are they still regarded as clinically important?
View morebeta-adrenoceptor blockers and pulmonary function in the general population: the Rotterdam Study
View morePhenotypes and genotypes for CYP2D6 and CYP2C19 in a black Tanzanian population
View moreThe airway effects of stopping regular oral theophylline in patients with asthma
View moreDiflunisal: efficacy in postoperative pain.
View moreChanges in antipsychotic drug prescribing by general practitioners in the United Kingdom from 1991 to 2000: a population-based observational study
View moreThe passage of cloxacillin into cerebrospinal fluid in the absence of meningitis.
View moreThe effects of KT3-671, a new angiotensin II (AT 1) receptor blocker in mild to moderate hypertension
View moreExpanded Access as a source of real-world data: An overview of FDA and EMA approvals
View moreThe influence of the hand circulation on the assessment of venous distensibility of the human forearm with venous occlusion plethysmography
View moreThe efficacy of parecoxib on systemic inflammatory response associated with cardiopulmonary bypass during cardiac surgery
View moreUltramolecular homeopathy has no observable clinical effects. A randomized, double-blind, placebo-controlled proving trial of Belladonna 30C
View moreDrugs Handbook 2003
View moreVariability of cytochrome P450 1A2 activity over time in young and elderly healthy volunteers
View more
Comments